Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
SCRI Development Innovations, LLC Identifier:
First received: January 28, 2008
Last updated: January 31, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)